As the United States confronts an ever-changing set of international challenges, our foreign policy leaders continue to offer the same old answers. But what are the alternatives? In None Of The Above, the Eurasia Group Institute for Global Affairs' Mark Hannah asks leading global thinkers for new answers and new ideas to guide an America increasingly adrift in the world. www.noneoftheabovepodcast.org
…
continue reading
Kandungan disediakan oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors
Manage episode 156760069 series 1199499
Kandungan disediakan oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination therapy of a TNF-alpha agent and methotrexate results in highly significant improvement in arthritic symptoms and signs.
…
continue reading
6 episod
Manage episode 156760069 series 1199499
Kandungan disediakan oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination therapy of a TNF-alpha agent and methotrexate results in highly significant improvement in arthritic symptoms and signs.
…
continue reading
6 episod
すべてのエピソード
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.